DNLI FY 2016 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

DNLIDenali Therapeutics Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$87M

Net Income

-$87M

EPS (Diluted)

$-13.49

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$78M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$271M

Total Liabilities

$17M

Stockholders' Equity

$255M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$121,000	-1114.0%
Operating Income	-$87M	-$17M	-424.2%
Net Income	-$87M	-$17M	-416.2%